The Andean Country authorized the commercialization of Vedevax Block, the first recombinant vaccine for the control of the virus. The product developed by Bioinnovo SA, a company created by a partnership between the National Institute of Agricultural Technology (INTA) of Argentina and the company Vetanco S.A., stands out for being efficient and safe. Its registration is also in progress in other countries from America, Asia and Africa.
28 Aug 2020
Por admin en Uncategorized